AIDSmeds: "The new WHO guidelines recommend that HIV-positive women who received single-dose regimen be subsequently treated with a regimen that doesn’t contain Viramune. However, because the danger for Viramune treatment failure diminishes over time, the guidelines also state that a Viramune-based regimen may be used in such women—if they start that regimen at least one year after receiving single-dose Viramune during the birthing process.
The new guidelines also give recommendations for treating infants who contract HIV despite receiving single-dose Viramune immediately after birth. In these infants, a subsequent treatment regimen should include Kaletra (lopinavir plus ritonavir) rather than Viramune."
0 comments:
Post a Comment